Description
(Text)
Imiquimod belongs to the class of topical response modifiers.
It influences both the innate and acquired immune defense systems through stimulation of Toll-like receptor 7. With its antiviral and antineoplastic action, Imiquimod cream alters local immunity in the Skin in the area of application.
Imiquimod cream has been approved for the treatment of condylomata acuminate, superficial basal cell carcinoma, and actinic keratosis. This volume provides a clear description of these clinical pictures
